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Background-—Increasing evidence suggests a psychosomatic link between neural systems and the heart. In light of the
growing burden of ischemic cardiovascular disease across the globe, a better understanding of heart-brain interactions and
their implications for cardiovascular treatment strategies is needed. Thus, we sought to investigate the interaction between
myocardial injury and metabolic alterations in central neural areas in patients with suspected or known coronary artery
disease.
Methods and Results-—The association between resting metabolic activity in distinct neural structures and cardiac function was
analyzed in 302 patients (aged 66.810.2 years; 70.9% men) undergoing ﬂuor-18-deoxyglucose positron emission tomography
and 99mTc-tetrofosmin single-photon emission computed tomography myocardial perfusion imaging. There was evidence for
reduction of callosal, caudate, and brainstem ﬂuor-18-deoxyglucose uptake in patients with impaired left ventricular ejection
fraction (<55% versus ≥55%: P=0.047, P=0.022, and P=0.013, respectively) and/or in the presence of myocardial ischemia (versus
normal perfusion: P=0.010, P=0.013, and P=0.016, respectively). In a sex-stratiﬁed analysis, these differences were observed in
men, but not in women. A ﬁrst-order interaction term consisting of sex and impaired left ventricular ejection fraction or myocardial
ischemia was identiﬁed as predictor of metabolic activity in these neural regions (left ventricular ejection fraction: P=0.015 for
brainstem; myocardial ischemia: P=0.004, P=0.018, and P=0.003 for callosal, caudate, or brainstem metabolism, respectively).
Conclusions-—Myocardial dysfunction and injury are associated with reduced resting metabolic activity of central neural
structures, including the corpus callosum, the caudate nucleus, and the brainstem. These associations differ in women and men,
suggesting sex differences in the pathophysiological interplay of the nervous and cardiovascular systems. ( J Am Heart Assoc.
2019;8:e013070. DOI: 10.1161/JAHA.119.013070.)
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tomography • myocardial perfusion imaging • nervous system, autonomic • sex
M yocardial function and perfusion are well-recognizedprognostic parameters for cardiovascular risk assess-
ment.1,2 However, the ever-increasing burden of cardiovas-
cular disease across the globe has prompted efforts to
discover new and effective risk predicting biomarkers to
confront this challenge. In addition, the demographic shift
towards an older population will result in an increase of
multimorbid and complex cardiovascular patients at high risk
of recurrent events after initial myocardial infarction.3 The
latter further emphasizes the need for an optimization of risk
predictors and secondary preventive measures in patients
with known coronary artery disease (CAD).4 In addition,
growing awareness of sexual dimorphism in prevalence,
pathophysiological features, and clinical manifestation of
CAD highlights the need to reconsider the conventional way
of cardiovascular risk assessment.5,6
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ORIGINAL RESEARCH
The past decade has seen an increasing interest in the ﬁeld
of neurocardiology. Indeed, cognition, structural brain integrity,
and heart-brain interactions have been suggested as potential
players in determining outcomes in cardiovascular patients7–9;
and a recent investigation identiﬁed resting metabolic activity
of the amygdala, a neural structure involved in emotional stress,
as an independent and robust predictor of major adverse
cardiovascular events in patients without known CAD.10 More
important, multiple studies have reported sex differences in
brain networks, neuroanatomic structure, and function. Indeed,
sex differences in volumes of the major cranial compartments
have been described, withwomen having a higher percentage of
graymatter and a lower percentage of whitematter thanmen,11
whereas a greater overall cortical connectivity in women seems
to account for some of the documented sex differences in
behavior.12,13 Likewise, sexual dimorphism has been exten-
sively documented for various cardiovascular pathological
conditions, such as CAD and heart failure.14,15 However, a
comprehensive analysis of how gender and sex modulate the
psychosomatic link between myocardial dysfunction and
central stress responses has not been performed. Thus, given
(1) the known sex differences in neural structure and function
and (2) the sexual dimorphism in cardiovascular disease
phenotypes, we sought to investigate the interaction between
myocardial injury and metabolic alterations in central neural
areas in a cohort of aged individuals with suspected or known
CAD.
Methods
Study Population
This retrospective cohort study comprises 25 600 patients
who underwent ﬂuor-18-deoxyglucose (18F-FDG) positron
emission tomography (PET; full body) for evaluation/follow-up
of malignant and/or inﬂammatory disorders and 10 148
patients who underwent 1-day stress/rest (adenosine, dobu-
tamine, or exercise) 99mTc-tetrofosmin myocardial perfusion
imaging–single-photon emission computed tomography (MPI-
SPECT) for evaluation of suspected or known CAD at our
department (November 1, 2007, to February 31, 2015). For
each patient, a non–contrast-enhanced computed tomography
(CT) scan for attenuation correction was acquired. A total of
332 study patients received both an MPI-SPECT and a full-body
18F-FDG PET/CT (meanSE time interval of 47.23.4 days in
men and 45.34.6 days in women). After exclusion of 24
patients because of insufﬁcient clinical data and 6 patients
because of poor image quality, 302 patients (70.9% men; mean
age, 66.810.2 years) remained in the ﬁnal study population.
Patients then underwent stratiﬁcation by sex and demographic
parameters. The patient’s history was acquired by review of
medical electronic records. Three patients underwent a
coronary revascularization between the 2 imaging examina-
tions. Our study was approved by the local ethics board
(Business Administration System for Ethics Committees
[BASEC] No. 2017-01112), and the study complies with the
Declaration of Helsinki and its later amendments. The need for
informed consent was waived by the local ethics board because
of the purely retrospective design of the present study. The
study population was shared with the PET/SPECT imaging
registry reported elsewhere.16 Because of the sensitive nature
of the data collected for this study, requests to access the data
set from qualiﬁed researchers trained in human subject
conﬁdentiality protocols may be sent to the Cantonal Ethics
Commission Zurich, Switzerland, at Info.KEK@kek.zh.ch.
99mTc-Tetrofosmin SPECT-MPI
All patients received a 1-day stress/rest and ECG-gated
protocol, as previously described.17 A dual-head camera was
used for MPI-SPECT acquisition (Discovery NM/CT 570c,
Inﬁnia Hawkeye, or Ventri; all GE Healthcare, Milwaukee, WI).
The camera was equipped with a high-resolution, low-energy
collimator (20% symmetric window, 64964 matrix, 140 keV).
Acquisitions were gated for 16 frames per R-R cycle with an
acceptance window of 50%. Mean heart rate during
acquisition was recorded for each scan. MPI-SPECT analysis
was performed by application of the Cedars QGS/QPS
software (Cedars-Sinai Medical Center, Los Angeles, CA),
according to present guidelines.18 Myocardial segments
were scored by use of a 20-segment model and a
Clinical Perspective
What Is New?
• Myocardial dysfunction and injury are associated with
reduced metabolic activity of central neural structures,
including the corpus callosum, the caudate nucleus, and the
brainstem.
• In men, but not in women, the presence of myocardial
ischemia is associated with blunted neural metabolic
activity in these structures.
• As nuclei within these brain regions have been identiﬁed as
key modulators of cardiorespiratory pathways, our data
suggest that the central adaption process to myocardial
injury is modulated by sex.
What Are the Clinical Implications?
• This study further supports the investigation of sex-speciﬁc
risk stratiﬁcation and disease management.
• Our data suggest that neural disease responses might carry
important prognostic information for cardiovascular disease
management.
• As the underlying mechanisms are not well understood, the
ﬁndings in this study should be considered hypothesis
generating.
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5-point scoring system (by consensus of at least ≥2
experienced readers): 0=normal; 1=equivocal; 2=moderate;
3=severe reduction of radioisotope uptake; and 4=absence of
radionuclide uptake in a segment. MPI was graded as
abnormal (myocardial ischemia and/or myocardial scar) if
stress scores in ≥2 segments were ≥2. A reversible perfusion
defect was classiﬁed as a stress defect with a rest score ≤1 or
a stress defect score of 4 with a rest score of 2. Left
ventricular (LV) volumes were retrieved from gated SPECT
data sets, and LV ejection fraction (LVEF) was calculated by
the ratio of stroke volume (end-diastolic volume–end-systolic
volume) and end-diastolic volume. SPECT-derived LV volumes
correlate well with LVEF measurements obtained by other
imaging methods, such as echocardiography and cardiac
magnetic resonance imaging.19 For attenuation correction
and acquisition of coronary artery calcium scoring (Agatston
units), a noncontrast CT examination (64-slice CT scanner;
LightSpeed VCT; GE Healthcare) was conducted with the
following settings: 6492.5-mm collimation, rotation time of
0.35 seconds, tube voltage of 120 kV, and tube current of
200 mA. Coronary artery calcium scoring calculation was
performed by application of the semiautomatic SmartScore
software (GE Healthcare). Coronary artery stent implantation
or bypass vessels were excluded for coronary artery calcium
scoring assessment.
Full-Body 18F-FDG PET/CT Technique and
Determination of Neural Resting Metabolic
Activity
18F-FDG PET imaging is routinely used for quantiﬁcation of
metabolic tissue activity in patients with inﬂammatory or
malignant pathological conditions.20,21 After measuring each
patient’s blood glucose level (6.51.7 mmol/L in men,
6.21.7 mmol/L in women; P=0.140), 18F-FDG (weight
adapted) was administered into a peripheral vein (330.4 MBq;
range, 180–525 MBq) and acquisition of PET image (skull to
pelvis), according to a standard protocol, was performed 45 to
60 minutes after tracer administration. Images were registered
in 3-dimensional mode on a Discovery VCT or a Discovery RX
scanner (both GE Healthcare). Fusion of PET/CT images was
conducted by application of a dedicated software package (AW
5.0; GE Healthcare).
Full-body scans were cropped to exclude all areas outside
the brain, and quantitative 18F-FDG resting uptake was
assessed by semiautomatically placing volumetric regions of
interest in distinct and representative neural structures,
including the corpus callosum, caudate nucleus, brainstem,
amygdala, hippocampus, thalamus, and insula (Figure 1),
using the PMOD software, version 3.7-3.8 (PMOD Technolo-
gies Ltd), developed/validated at our institution,22–24 includ-
ing a brain-segmentation module. Mean tracer accumulation
was quantiﬁed as standardized uptake value (SUV). Correction
for cerebellar metabolic activity to reduce partial volume
effects and interindividual alterations of brain activity was
performed by dividing mean SUV values of the respective
brain regions by cerebellar mean SUV (gray and white matter),
as reported previously.10,25 As a marker for systemic
inﬂammation, 18F-FDG bone marrow uptake was assessed
by placing volumes of interest in the center of vertebral
bodies starting from thoracic vertebra 1 to lumbar vertebra 5.
18F-FDG bone marrow uptake was quantiﬁed using mean SUV
(corrected for background activity).
Statistical Analysis
The mean and SD are reported for continuous variables,
whereas frequencies and percentages are reported for cate-
gorical variables. Distribution of data was veriﬁed before
further analysis by Q-Q normality and histogram plots, where
appropriate. Levene’s test was used to assess equality of
variances in the sex-stratiﬁed data set. Comparison of variables
was conducted by use of the following statistical tests, as
appropriate: Student t test, ANOVA, or v2 test. Pearson
product-moment test was used to identify correlations. For
further analysis, LVEF was dichotomized into <55% (patholog-
ical) and ≥55% (normal), according to current guidelines.26
After stratiﬁcation by sex, a linear regression model was used
to evaluate the association between resting metabolic activity
in central neural regions and LVEF or abnormal myocardial
perfusion (reversible/ﬁxedmyocardial perfusion defect). In this
model, the independent variable not in the equation that has
the smallest probability of F is entered at each step, if that
probability is sufﬁciently small (≤0.05). Variables already in the
regression equation are removed if their probability of F
becomes sufﬁciently large (≥0.1). The method terminates when
no more variables are eligible for inclusion or removal. The
regression model was performed among known predictors of
CAD, including obesity (body mass index ≥30 kg/m2), current
smoking, diabetes mellitus, dyslipidemia, hypertension,
positive family history of CAD, and age, as well as known
CAD, previous myocardial infarction, use of antidepressants,
18F-FDG bone marrow uptake (as a surrogate marker of
inﬂammation), and active cancer. Furthermore, in the total
study population, an interaction term consisting of either sex
and LVEF or sex and abnormal myocardial perfusion was
entered in the abovemodel by using otherwise similar predictor
variables. All statistical tests were 2-sided. Given the explo-
rative nature of this analysis, no prespeciﬁed level of signiﬁ-
cance was chosen; rather, the level of evidence was graded on
a continuous scale, as previously recommended,27 and P values
were quantiﬁed according to their level of evidence. Statistical
analyses were performed using IBM SPSS, version 25.0 (IBM
Corp, Armonk, NY).
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Results
Study Population
The association between resting metabolic activities in
different neural structures and cardiac function was analyzed
in 302 patients (70.9% men). Mean age was 66.010.2 years
for men and 69.010.0 years for women (P=0.018). Vari-
ances for continuous variables were found to be equal
between men and women (Levene’s test P=0.564 for LVEF,
P=0.193 for body mass index, and P=0.616 for age),
indicating homogeneity across samples. In particular, there
was no evidence for a difference in the prevalence of chronic
pain, depression, or active cancer between male and female
individuals in our study sample (P=0.491, P=0.756, or
P=0.642, respectively). A detailed overview of sex-stratiﬁed
demographic characteristics is given in Table 1. Prevalence of
cancer types in the total study population was as follows: lung
(33.2%), esophageal/gastric (15.5%), colorectal (9.3%), oral/
esophageal/laryngeal (7.8%), liver (6.7%), gallbladder/bile
path (6.7%), pancreatic (5.2%), mamma (3.6%), hematopoietic
(3.6%), genitourinary (3.1%), skin (2.6%), kidney (1.6%), and
soft tissue/other (1.1%).
Association Between LVEF and Myocardial
Ischemia With Resting Callosal, Caudate, and
Brainstem Metabolic Activity
In the overall population, among all analyzed central neural
regions, resting metabolic activity in the corpus callosum, the
caudate nucleus, and the brainstem showed the strongest
associations with cardiac function and/or perfusion. An
overview of the analyzed neural structures in the total
population is given in Table 2.
When the study cohort was stratiﬁed by sex, in men with
impaired LVEF <55%, but not in women, 18F-FDG uptake was
reduced in the callosal, caudate, and brainstem region,
compared with men with normal LVEF (SUV of 58.337.4
versus 68.433.2, P=0.047; 14.94.4 versus 16.23.6,
P=0.022; and 4.51.4 versus 4.91.1, P=0.013, respectively;
Figure 2A through 2C for men; Figure 3A through 3C for
women). Furthermore, in these 3 neural regions, a reduced 18F-
FDG uptake was detected in men with myocardial ischemia
compared with men with normal myocardial perfusion (SUV of
50.833.4 versus 67.934.4, P=0.010; 14.24.6 versus
16.03.7, P=0.013; and 4.31.5 versus 4.91.2, P=0.016;
Figure 2D through 2F for men; Figure 3D through 3F for
Figure 1. Volumetric analysis of central neural structures (using PMOD software). Illustrative axial
positron emission tomography slices depicting region of interests (white arrows) around the corpus
callosum (yellow; A), the right and left caudate nucleus (red; B), the brainstem (orange; C), the right and left
amygdala (yellow; D)/hippocampus (dark green; D), the right and left thalamus (light green; E), and the right
and the left insula (gray; F).
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Table 1. Patient Baseline Characteristics
Patient Characteristics Total (n=302) Men (n=214) Women (n=88) P Value (Men vs Women)
Age, meanSD, y 66.810.2 66.010.2 69.010 0.018
BMI, meanSD, kg/m2 28.117.3 27.414.7 29.722.8 0.769
Hypertension, n (%) 142 (47) 100 (46.7) 42 (47.7) 0.874
Smoking, n (%) 93 (30.8) 73 (34.1) 20 (22.7) 0.058
Diabetes mellitus, n (%) 56 (18.5) 42 (19.6) 14 (15.9) 0.450
Dyslipidemia, n (%) 73 (24.2) 53 (24.8) 20 (22.7) 0.707
Family history of CAD, n (%) 25 (8.3) 14 (6.5) 11 (12.5) 0.088
Known CAD, n (%) 117 (38.7) 92 (43) 25 (28.4) 0.018
Previous MI, n (%) 57 (18.9) 44 (20.6) 13 (14.8) 0.243
Previous PCI/CABG, n (%) 82 (27.2) 65 (30.4) 17 (19.3) 0.050
CACS >75th percentile, n (%) 95 (31.5) 65 (30.4) 30 (34.1) 0.896
Myocardial ischemia, n (%) 37 (12.3) 31 (14.5) 6 (6.8) 0.065
Myocardial scar, n (%) 60 (19.9) 49 (22.9) 11 (12.5) 0.040
Abnormal myocardial perfusion, n (%) 79 (26.2) 64 (29.9) 15 (17) 0.021
Active cancer, n (%) 193 (63.9) 135 (63.1) 58 (65.9) 0.642
Depression, n (%) 19 (6.3) 14 (6.5) 5 (5.7) 0.756
Chronic pain, n (%) 90 (29.8) 66 (30.8) 24 (27.3) 0.491
b Blocker, n (%) 146 (48.3) 112 (52.3) 34 (38.6) 0.015
ACE/ARB, n (%) 156 (51.7) 112 (52.3) 44 (50) 0.547
Statin, n (%) 126 (41.7) 88 (41.1) 38 (43.2) 0.875
P2Y12 inhibitor, n (%) 27 (8.9) 21 (9.8) 6 (6.8) 0.372
ASS, n (%) 128 (42.4) 98 (45.8) 30 (34.1) 0.037
Antidepressant, n (%) 33 (10.9) 22 (10.3) 11 (12.5) 0.601
Corticosteroid, n (%) 40 (13.2) 28 (13.1) 12 (13.6) 0.932
Analgesics, n (%) 135 (44.7) 95 (44.4) 40 (45.5) 0.945
LVEF, meanSD, % 58.713.2 56.312.7 64.212.9 <0.001
18F-FDG bone marrow uptake, meanSD, SUV 1.60.6 1.60.5 1.70.6 0.036
Indication for SPECT, n (%)
Preoperative evaluation 186 (61.6) 126 (58.9) 60 (68.2) 0.131
Known CAD 60 (19.9) 46 (21.5) 14 (15.9) 0.269
Suspected CAD 56 (18.5) 42 (19.6) 14 (15.9) 0.450
Indication for PET, n (%)
Inflammation 46 (15.2) 35 (16.4) 11 (12.5) 0.397
Cancer 256 (84.8) 179 (83.6) 77 (87.5) 0.397
Symptoms, n (%)
Typical angina pectoris 30 (9.9) 24 (11.2) 6 (6.8) 0.246
Atypical angina pectoris 23 (7.6) 13 (6.1) 10 (11.4) 0.115
Dyspnea 39 (12.9) 22 (10.3) 17 (19.3) 0.033
None 210 (69.5) 155 (72.4) 55 (62.5) 0.088
Data are presented as meanSD or frequencies (percentages). Two-sided P values are indicated. ACE/ARB indicates angiotensin-converting enzyme/angiotensin II receptor blocker; ASS,
acetylsalicylic acid; BMI, body mass index; CABG, coronary artery bypass graft; CACS, coronary artery calcium score; CAD, coronary artery disease; 18F-FDG, ﬂuor-18-deoxyglucose; LVEF,
left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; PET, positron emission tomography; SPECT, single-proton emission computed
tomography.
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women). Similarly, a positive correlation was observed between
LVEF and resting 18F-FDG uptake (Pearson r=0.150 and
P=0.032 for callosal region; r=0.155 and P=0.027 for caudate
region; r=0.160 and P=0.022 for brainstem; data not shown). In
contrast, no difference in resting callosal, caudate, or brainstem
18F-FDG uptake was detected between male patients with or
without cardiovascular risk factors (data not shown).
Prognostic Value of Myocardial Function and
Perfusion on Resting Callosal, Caudate, and
Brainstem Metabolic Activity
The association between LVEF and resting 18F-FDG uptake in all
3 neural centers was initially analyzed in a sex-stratiﬁed linear
regression model adjusted for active cancer, age, antidepres-
sants (data on antidepressant medication available in 282
patients), current smoking (smoking status available in 301
patients), dyslipidemia, hypertension, known CAD, previous
myocardial infarction, obesity, 18F-FDG bone marrow uptake
(available in 294 patients), and positive family history of CAD.
Although LVEF was not predictive for corpus callosum and
caudate nucleus activity, LVEF was selected as a predictor of
brainstem 18F-FDG uptake in men, but not in women (B
coefﬁcient [SE], 0.014 [0.007]; P=0.044). Accordingly, in the
total population, an interaction term consisting of sex and LVEF
was evident (B coefﬁcient [SE], 0.016 [0.007]; P=0.015).
Furthermore, inmen, but not in women,myocardial ischemia
was selected as an independent predictor of corpus callosum
Table 2. Impact of Neural Structures on Cardiac Function and Perfusion
Neural Structures Cardiac Function and Perfusion Parameters
Total Population (n=302), SUV
P ValuePresent Absent
Corpus callosum LVEF <55% vs ≥55% 62.839.3 71.232.6 0.056
Reversible myocardial perfusion defect 56.535.5 70.634.2 0.020
Fixed myocardial perfusion defect 63.534.3 70.334.7 0.176
Abnormal myocardial perfusion 62.635.0 71.234.3 0.058
Caudate nucleus LVEF <55% vs ≥55% 15.34.5 16.53.6 0.016
Reversible myocardial perfusion defect 14.84.6 16.33.7 0.023
Fixed myocardial perfusion defect 16.03.9 16.23.9 0.767
Abnormal myocardial perfusion 15.84.2 16.33.7 0.305
Brainstem LVEF <55% vs ≥55% 4.61.4 5.01.0 0.005
Reversible myocardial perfusion defect 4.41.4 4.91.1 0.025
Fixed myocardial perfusion defect 4.81.2 4.91.2 0.884
Abnormal myocardial perfusion 4.81.3 4.91.1 0.398
Amygdala LVEF <55% vs ≥55% 29.36.0 29.75.1 0.536
Reversible myocardial perfusion defect 28.56.4 29.85.2 0.182
Fixed myocardial perfusion defect 29.66.3 29.65.1 0.982
Abnormal myocardial perfusion 29.86.3 29.55.0 0.751
Hippocampus LVEF <55% vs ≥55% 20.53.4 20.53.2 0.857
Reversible myocardial perfusion defect 19.73.7 20.63.1 0.091
Fixed myocardial perfusion defect 20.43.5 20.53.1 0.874
Abnormal myocardial perfusion 20.53.5 20.53.1 0.851
Thalamus LVEF <55% vs ≥55% 18.36.8 20.25.8 0.014
Reversible myocardial perfusion defect 18.47.8 19.95.8 0.178
Fixed myocardial perfusion defect 19.65.7 19.76.2 0.968
Abnormal myocardial perfusion 19.56.8 19.75.9 0.747
Insula LVEF <55% vs ≥55% 6.31.0 6.40.8 0.221
Reversible myocardial perfusion defect 6.10.9 6.40.9 0.121
Fixed myocardial perfusion defect 6.31.0 6.40.9 0.480
Abnormal myocardial perfusion 6.31.0 6.40.9 0.385
Data are presented as meanSD. Values available in >200 patients. Two-sided P values are indicated. LVEF indicates left ventricular ejection fraction; SUV, standardized uptake value.
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metabolic activity (B coefﬁcient [SE], 19.710 [6.572];
P=0.003), caudate nucleus activity (B coefﬁcient [SE],
1.789 [0.763]; P=0.020), and brainstem metabolic activity
(B coefﬁcient [SE],0.667 [0.238]; P=0.006) in a sex-stratiﬁed
linear regression model adjusted for the same predictor
variables as above. Accordingly, an interaction term consisting
of sex and myocardial ischemia was selected as a predictor of
metabolic activity in these brain regions (corpus callosum: B
coefﬁcient [SE], 18.585 [6.423], P=0.004; caudate nucleus:
B coefﬁcient [SE], 1.789 [0.754], P=0.018; brainstem: B
coefﬁcient [SE], 0.664 [0.221], P=0.003) when the total
population was analyzed.
Discussion
This study provides evidence that myocardial ischemia is
linked with central neural structure metabolic activity in
patients with CAD. Our data suggest that these associations
are sex speciﬁc, as alterations in resting metabolic activity in
the corpus callosum, caudate nucleus, and brainstem were
observed in men with myocardial ischemia, but not in women.
Accordingly, in men, but not in women, the presence of
myocardial ischemia was selected as a predictor of blunted
neural metabolic activity in a fully adjusted multivariate linear
regression model. As nuclei within these brain regions have
been identiﬁed as key modulators of cardiorespiratory
pathways and cardiac sympathetic activity, our data suggest
that the central adaption process to myocardial injury is
modulated by sex.
It is well known that cardiac conditions, such as atrial
ﬁbrillation or congestive heart failure, can lead to cerebrovas-
cular accidents.28 However, even in the absence of manifest
stroke, atrial ﬁbrillation has been associated with cognitive
impairment and hippocampal atrophy, thereby indicating that
Figure 2. Association of callosal, caudate, and brainstem resting metabolic activity with cardiac
function and perfusion in men. A through C, Dichotomous comparison of left ventricular ejection
fraction (LVEF) ≥55% vs <55% with ﬂuor-18-deoxyglucose (18F-FDG) resting callosal, caudate, and
brainstem uptake (standardized uptake value [SUV]). D through F, Dichotomous comparison of 18F-
FDG resting callosal, caudate, and brainstem uptake in absence or presence of myocardial
ischemia. Error bars indicate SE, and P values are depicted.
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neurocardiac interrelations cannot solely be explained by a
simplistic cause-and-effect model.29 Our data further support
this link between neural systems and the viscera by
demonstrating an association between ongoing myocardial
ischemia and metabolic activities in central neural structures,
including the brainstem. Although the subcortical forebrain
(hypothalamus and amygdala) plays a pivotal role in central
stress responses, nuclei located within the brainstem, such as
the caudal ventrolateral medulla and the rostral ventrolateral
medulla, have emerged as key modulators of cardiorespira-
tory pathways and cardiac sympathetic activity.30–33 Accord-
ingly, chemical inactivation of the rostral ventrolateral medulla
has been shown to reduce sympathetic reﬂexes and barore-
ceptor responses mediated via GABAergic neurons or
ionotropic glutamate receptors.31,34,35 Given the persistent
and deleterious activation of the sympathetic nervous system
observed in patients with ischemic heart disease,36 the
reduced 18F-FDG uptake seen in this region in our study
points toward a neuroendocrine adaption process occurring in
these cardiomodulatory regions as an answer to burst
stressful stimulation from myocardial ischemia. Consistent
with previous studies reporting sexual dimorphism in vegeta-
tive control of the cardiovascular system,37 we did not
observe this “desensitization” process in women, as no
alteration of brainstem 18F-FDG uptake was noticed in this
demographic group.
Although sex differences in multiorgan cross talk in
cardiovascular disease are widely unexplored, it is conceivable
Figure 3. Association of callosal, caudate, and brainstem resting metabolic activity with cardiac function
and perfusion in women. A through C, Dichotomous comparison of left ventricular ejection fraction (LVEF)
≥55% vs <55% with ﬂuor-18-deoxyglucose (18F-FDG) resting callosal, caudate, and brainstem uptake
(standardized uptake value [SUV]). D through F, Dichotomous comparison of 18F-FDG resting callosal,
caudate, and brainstem uptake in absence or presence of myocardial ischemia. Error bars indicate SE, and
P values are depicted.
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that a differential activation of the sympathetic nervous system
inmen and womenmight account for the sex-speciﬁc pattern of
neural responses to cardiac injury. Indeed, an enhanced
cardiac sympathetic activity has been described in women
with heart failure.38,39 In addition, Tawakol et al have recently
reported a link between regional brain activity, arterial
inﬂammation, and long-term cardiovascular outcomes.10
Similarly, experimental data demonstrate an inﬂam-
masome-dependent activation of interleukin-18 through b-
adrenergic receptor overactivation in the myocardium.40 Thus,
given the well-described differences in male and female
immune responses, a sex-speciﬁc activation pattern of the
neural-inﬂammatory-cardiac axis might be a key mechanism
accounting for the observed sexual dimorphism in heart-brain
communication. Indeed, a model in which inﬂammation
accentuates sex differences in both, brain networks and
preexisting vulnerability factors, has recently been sug-
gested.41,42 Finally, it is known that physiological testosterone
levels exert neuroprotective effects on hippocampal volume
and cognitive status in men,43,44 whereas low testosterone was
associated with demyelination of the corpus callosum in a
mouse model of hormone withdrawal.45 Given the advanced
age of our male study cohort and taking into account the age-
dependent decline in circulating testosterone levels, a delete-
rious effect of low testosterone on brainstem structures might
play a role in the observed alterations in neural metabolism in
men with ischemic heart disease.
Various cardiovascular diseases are intertwined with psy-
chopathological conditions, such as depression, anxiety, or
other stress-related disorders.36,46,47 The coexistence of these
conditions with myocardial disease is associated with unfavor-
able cardiovascular outcomes and represents a serious quan-
titative problem in Western societies. A potential mechanism
for such a mutually reinforcing cycle between neural centers
and the heart was provided by a recent study demonstrating a
link between higher resting metabolic activity in the amygdala,
a neural center of the brain’s limbic system involved in
emotional stress, and adverse cardiovascular outcomes.10 By
further extending these ﬁndings, we have recently observed
that the associations between cardiovascular pathological
conditions and the limbic system are sex-speciﬁc.16 However, it
is well described that stress-related mental disease not only
induces changes of neural metabolic activity but also alters
cognition and structural brain integrity, with some studies
suggesting that these alterations are more prominent in
men.48–51 Indeed, a reduced volume of the posterior corpus
callosum and, consequently, reduced interhemispheric con-
nectivity was recently measured in patients with posttraumatic
stress disorder.52 Furthermore, diffusion tensor imaging stud-
ies show a decreased fractional anisotropy as well as smaller
volumes of the caudate nucleus in patients with posttraumatic
stress disorder, thereby suggesting macrostructural and
microstructural alterations in the presence of chronic
stress.53,54 Finally, as the caudate nucleus is perceived as
the central brain structure associated to “stimulus-control”
learning,55 the observed caudate hypoactivity in patients with
impaired myocardial function might render this population even
more vulnerable because of potential incompliance toward
medical treatment.
Chronic stress has been associated with subregional and
selective serotonin cell death in the brainstem’s dorsal raphe
nuclei in male rats,56 which is consistent with serotonin being a
key player in modulating sympathetic tone and hypoxia via
nuclei in the brainstem.30 Interestingly, previous experimental
studies report higher brainstem serotonin levels in female rats
compared with their male counterparts.57 In addition, it is
known from large cohorts that women in general have a higher
baseline LVEF compared with men and, paradoxically, show
enhanced salvage of ischemic myocardium after reperfusion,
despite an overall worse outcome.58,59 As dysregulation of
serotonin concentrations in the synaptic cleft seems to be
associated with altered metabolic rates of neurons in the
brainstem,30 one could hypothesize that higher baseline
regional serotonin concentrations along with a preserved
cardiac output in the presence of ischemic heart disease might
exert a neuroprotective effect in women, leading to preserved
metabolic activities in the brainstem. Furthermore, a recent
investigation by Templin et al indicates that hypoconnectivity
of central brain regions (ie, amygdala, hippocampus, insula,
cingulate, parietal, temporal, and cerebellar regions) is asso-
ciated with autonomic regulation and function of the limbic
system in patients with Takotsubo syndrome, a syndrome
affecting mainly women who encounter acute LV dysfunction,
often resulting from severe emotional stress.60 Although these
authors did not investigate callosal, caudate, or brainstem
interconnectivity, their ﬁndings further emphasize the impor-
tance of understanding the complex interrelation of neural
structures with cardiovascular pathological conditions.
The following study limitations should be pointed out. First,
our study is a single-center, retrospective study with a limited
number of patients and is subject to all of the limitations of
this study design. In addition, more male than female study
participants were included in our analysis. The latter may lead
to a referral bias and limited generalization of the results.
Second, although potential changes in coronary circulation
between the 2 imaging examinations cannot be excluded, the
mean time interval between both examinations was only
47 days in both men and women. Third, the population of this
study encompasses a heterogeneous group of patients,
including 63.1% male and 65.9% female patients with active
malignancies (Table 1). Although our linear regression models
were adjusted for the presence or absence of active cancer,
we cannot completely rule out residual confounding of
ongoing systemic chemotherapy, time lag since previous
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myocardial infarction, age-associated neurodegeneration, and
brain atrophy, or a potential interaction with the amount of
18F-FDG uptake in neural structures. Finally, volumetric region
of interest analysis was based on PET images only, as patients
did not undergo simultaneous magnetic resonance imaging–
based neuroimaging. Therefore, accurate regional determina-
tion of central neural structures was limited, and standard
partial volume correction was not performed. However, only
clearly depictable subcortical structures with stable metabolic
variance were investigated in our study; and we did not intend
to assess cortical regions showing a high degree of metabolic
variation.
Collectively, this investigation is the ﬁrst to demonstrate a
sex-speciﬁc connection between myocardial ischemia and
resting metabolic activity in distinct neural centers, such as
the corpus callosum, the caudate nucleus, and the brainstem.
Our ﬁndings further indicate that myocardial disease is
differentially associated with these central neural structures
in female and male individuals, suggesting that the patho-
physiological interplay of the nervous and cardiovascular
system is sex-dependent. However, further work is required to
better understand underlying mechanisms, such as the action
of serotonin or testosterone, as well as potential clinical
implications for diagnosis and treatment of cardiovascular
pathological conditions.
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